BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8392828)

  • 1. [A combination chemotherapy of carboplatin and etoposide for malignant fibrous histiocytoma with marked effect on the metastatic lung region].
    Yasuno K; Matsunaga W; Ishihara T
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1253-6. PubMed ID: 8392828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary malignant fibrous histiocytoma treated with cisplatin plus etoposide followed by surgery].
    Morikawa T; Takeuchi K; Furuie H; Kimura M; Fukumura M; Kakuta Y; Tashiro Y; Konishi T; Hayashi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):993-8. PubMed ID: 8538096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
    Kito M; Umeda T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful chemotherapy and concurrent radiotherapy for metastatic lung. mediastinal malignant fibrous histiocytoma].
    Ishihama H; Ikeda Y; Shimada K
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Oct; 43(10):1757-61. PubMed ID: 7594834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
    Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report].
    Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged remission of metastatic malignant fibrous histiocytoma induced by combination chemotherapy.
    Clamon GH; Robinson RA; Olberding EB
    J Surg Oncol; 1984 Jun; 26(2):113-4. PubMed ID: 6330457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
    Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
    Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
    Tada A; Ueoka H; Kiura K; Tabata M; Takemoto M; Yamane H; Hiyama J; Aoe K; Shibayama T; Kamei H; Kawahara S; Harita S; Sato T; Kobayashi M; Eguchi K; Hiraki S; Hiraki Y; Tanimoto M
    Gan To Kagaku Ryoho; 2002 May; 29(5):751-6. PubMed ID: 12040679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remarkable effect of the combination therapy of etoposide, epiadriamycin, and CDDP (EAP) in the treatment of metachronous lung metastases of breast cancer--a case report].
    Kawabe T; Honda I; Kawakami Y; Fujita M; Watanabe K; Ryu M; Watanabe S; Yoshida M; Matsushita K
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2467-9. PubMed ID: 1659328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy].
    Kaira K; Watanabe R; Takise A; Endou K; Kamiyoshihara M; Mori M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1989-92. PubMed ID: 16282742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
    Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
    Anticancer Res; 1997; 17(6D):4755-8. PubMed ID: 9494602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of primary malignant fibrous histiocytoma of the lung].
    Saga K; Sato T; Abiko M; Takahashi N; Ikeda E
    Kyobu Geka; 2001 Mar; 54(3):191-4. PubMed ID: 11244748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer.
    Ghielmini M; Pagani O; de Jong J; Pampallona S; Conti A; Maestroni G; Sessa C; Cavalli F
    Br J Cancer; 1999 Jun; 80(7):1058-61. PubMed ID: 10362116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD; Stroup SL; Greco FA
    Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
    Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
    Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
    Hainsworth JD; Spigel DR; Litchy S; Greco FA
    J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.